Aesica Pharmaceuticals is Pharmaceuticals in United Kingdom that focus on secondary stage business. Founded in 2004. They cover business area such as developer, manufacturer, pharmaceutical product, contract, manufacture primary, API, secondary stage, finished product dosage form) pharmaceutical, active pharmaceutical ingredient, formulation development, formulated product, pharmaceutical support service.
2004
( 20 years old in 2024 )
Secondary Stage
-
Q5 Quorum Business Park
Benton Lane
Newcastle NE12 8BS
England, United Kingdom
Private
developermanufacturerpharmaceutical productcontractmanufacture primaryAPIsecondary stagefinished product dosage form) pharmaceuticalactive pharmaceutical ingredientformulation developmentformulated productpharmaceutical support service
* We use standard office opening hours in near Aesica Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Aesica Pharmaceuticals is Pharmaceuticals business from United Kingdom that founded in 2004 (20 years old in 2024), Aesica Pharmaceuticals business is focusing on Secondary Stage.
Aesica Pharmaceuticals headquarter office and corporate office address is located in Q5 Quorum Business Park Benton Lane Newcastle NE12 8BS England, United Kingdom.
Aesica Pharmaceuticals was founded in United Kingdom.
In 2024, Aesica Pharmaceuticals is currently focus on secondary stage sector.
Above is snippet of Google Trends for "secondary stage" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Aesica Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
